Among commonly used local anesthetics, which one is associated with methemoglobinemia risk?

Among commonly used local anesthetics, which one is associated with methemoglobinemia risk?

• A. Prilocaine
• B. Lidocaine
• C. Articaine
• D. Bupivacaine

Answer: (A)

Methemoglobinemia risk from local anesthetics mainly comes from how a drug is metabolized. Prilocaine has a metabolite called o-toluidine that acts as an oxidizing agent on hemoglobin. It converts the iron in hemoglobin from the ferrous state (Fe2+) to the ferric state (Fe3+), producing methemoglobin. Methemoglobin can’t bind oxygen effectively, so oxygen delivery to tissues drops, which can cause cyanosis and symptoms like headache, dizziness, and shortness of breath. The risk is dose-related, being higher with larger doses or topical formulations (for example, when using prilocaine in EMLA cream) or repeated dosing. In contrast, lidocaine, articaine, and bupivacaine have a much lower risk of methemoglobinemia at typical dental doses. If methemoglobinemia occurs, treatment with methylene blue is effective unless the patient has a contraindication such as G6PD deficiency.

Methemoglobinemia risk from local anesthetics mainly comes from how a drug is metabolized. Prilocaine has a metabolite called o-toluidine that acts as an oxidizing agent on hemoglobin. It converts the iron in hemoglobin from the ferrous state (Fe2+) to the ferric state (Fe3+), producing methemoglobin. Methemoglobin can’t bind oxygen effectively, so oxygen delivery to tissues drops, which can cause cyanosis and symptoms like headache, dizziness, and shortness of breath. The risk is dose-related, being higher with larger doses or topical formulations (for example, when using prilocaine in EMLA cream) or repeated dosing. In contrast, lidocaine, articaine, and bupivacaine have a much lower risk of methemoglobinemia at typical dental doses. If methemoglobinemia occurs, treatment with methylene blue is effective unless the patient has a contraindication such as G6PD deficiency.